Hyperfine Forms Global Neurosurgery Advisory Council

Hyperfine Inc. has formed a Neurosurgery Advisory Council, a multidisciplinary group of neurosurgeons who will provide expertise on the potential role of portable ultra-low-field MRI in neurosurgical applications and shape the future of imaging in neurosurgical care.

“The neurosurgical setting is becoming an important site of care for accessible imaging, where traditional MRI has intrinsic limitations. The Swoop system may open up new possibilities for integrating imaging directly into surgical workflows,” Hyperfine Chief Operating Officer Tom Teisseyre stated. “Providing access to imaging at key moments around a procedure may help clinical teams make better-informed decisions, improve efficiency, and ultimately advance how surgical care is delivered.”

The Neurosurgery Advisory Council brings together neurosurgeons from academic medical centers and community hospitals worldwide, representing expertise in craniotomy, endovascular neurosurgery, transsphenoidal surgery, tumor resection, and other complex procedures. Together, members will help evaluate the Swoop system’s potential role across the neurosurgical continuum—from preoperative planning and intraoperative decision-making to postoperative monitoring and discharge. The council will provide strategic clinical guidance on workflow integration, product development, and evidence generation while sharing real-world experience that may help define best practices and expand the clinical utility of portable MRI across neurosurgical subspecialties.

“The neurosurgical community has long recognized the value of intraoperative MRI, but access has been limited by the substantial infrastructure requirements, cost, and workflow demands of having a high-field MRI system in the OR,” Hyperfine Chief Medical Officer Edmond Knopp, M.D., stated. “Portable, ultra-low field MRI has the potential to fundamentally change how and where imaging is used throughout the neurosurgical care pathway. Through collaboration with experts in the field, we aim to accelerate its integration into clinical practice and maximize its impact on surgical decision-making and patient care.”

The initial members include:

• Hakan Emmez, M.D., Ph.D., professor of Neurosurgery at Güven Hospital in Ankara, Turkey
• Brian Jankowitz, M.D., chief of Neurosurgery at JFK University Medical Center in Edison, N.J.
• Elad I. Levy, M.D., professor and chair at the University at Buffalo Neurosurgery in Buffalo, N.Y.
• G. Michael Lemole Jr., M.D., neurosurgeon (skull base and cranial surgery) at Jefferson Abington Hospital and professor in the Department of Neurological Surgery at Thomas Jefferson University in Abington, Pa.
• Debraj “Raj” Mukherjee, M.D., associate professor and assistant Residency Program director, Department of Neurosurgery, at Johns Hopkins Medical Institutions in Baltimore
• Todd Patrick, M.D., Ph.D., chief of Neurosurgery at Christus Trinity Mother Frances Health System in Tyler, Texas
• Michael Schulder, M.D., professor and vice chairman, Department of Neurosurgery at Zucker School of Medicine within Hofstra/Northwell in Manhasset, N.Y.
• Adnan Siddiqui, M.D., Ph.D., vice chairman and professor of Neurosurgery at the Jacobs School of Medicine & Biomedical Sciences in Buffalo, N.Y.
• Julian Spears, M.D., head, Division of Neurosurgery; chair in Brain Tumor and Cerebrovascular Surgery at St. Michael’s Hospital, Unity Health Toronto, Department of Surgery at the University of Toronto in Toronto

By convening neurosurgeons across subspecialties and care settings, Hyperfine aims to accelerate evaluation of portable MRI in neurosurgical workflows and help expand the Swoop system’s clinical utility.

The Swoop Portable MR Imaging Systems are U.S. Food and Drug Administration (FDA)-cleared for brain imaging of patients of all ages. They are portable, ultra-low-field magnetic resonance imaging devices for producing images that display the head’s internal structure where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.

Hyperfine Inc. is the health technology company that claims to have redefined brain imaging with the Swoop system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. Hyperfine aims to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine Inc. scientists, engineers, and physicists developed the Swoop system to redefine brain imaging methodology and the way clinicians can apply accessible diagnostic imaging to patient care.